Human Hepatocyte Growth Factor (hHGF)-Modified Hepatic Oval Cells Improve Liver Transplant Survival

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Li, Zhu ^a   Chen, Juan ^a   Li, Li ^b   Ran, Jiang Hua ^b   Li, Xue Hua ^a   Liu, Zhi Heng ^a   Liu, Gui Jie ^a   Gao, Yan Chao ^a   Zhang, Xue Li ^a   Sun, Hiu Dong ^a  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

^b First People's Hospital of Kunming   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; N (2 FLUORENYL)ACETAMIDE; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BILE DUCT; CELL PROLIFERATION; CELL TRANSPLANTATION; DISEASE SEVERITY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; IN VITRO STUDY; LIVER CELL; LIVER GRAFT; LIVER INJURY; LIVER RESECTION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PLASMID; RAT; RECIPIENT; STABLE TRANSFECTION; SURVIVAL TIME;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CYTOKINES; GRAFT REJECTION; GRAFT SURVIVAL; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; RATS; STEM CELL TRANSPLANTATION; STEM CELLS; SURVIVAL RATE;

RATTUS;

EID: 84866517888     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044805     Document Type: Article

References (31)

1. Kaufman DB, Shapiro R, Lucey MR, Cherikh WS, R TB, et al. (2004) Immunosuppression: practice and trends. Am J Transplant 4 Suppl 9: 38-53.
2. Knechtle SJ, Kwun J, (2009) Unique aspects of rejection and tolerance in liver transplantation. Semin Liver Dis 29: 91-101.
3. Tosh D, Strain A, (2005) Liver stem cells-prospects for clinical use. J Hepatol 42 Suppl: S75-84.
4. Faris RA, Konkin T, Halpert G, (2001) Liver stem cells: a potential source of hepatocytes for the treatment of human liver disease. Artif Organs 25: 513-521.
5. Fausto N, Campbell JS, (2003) The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 120: 117-130.
6. Smets F, Najimi M, Sokal EM, (2008) Cell transplantation in the treatment of liver diseases. Pediatr Transplant 12: 6-13.
7. Matsumoto K, Nakamura T, (1996) Emerging multipotent aspects of hepatocyte growth factor. J Biochem 119: 591-600.
8. Huh CG, Factor VM, Sanchez A, Uchida K, Conner EA, et al. (2004) Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci U S A 101: 4477-4482.
9. Kato H, Shimomura T, Murai R, Gonda K, Ishii K, et al. (2007) Regulation of hepatic oval cell proliferation by adenoviral mediated hepatocyte growth factor gene transfer and signal transduction inhibitors. Hepatogastroenterology 54: 821-825.
10. Hasuike S, Ido A, Uto H, Moriuchi A, Tahara Y, et al. (2005) Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats. J Gastroenterol Hepatol 20: 1753-1761.
11. Shiota G, Kunisada T, Oyama K, Udagawa A, Nomi T, et al. (2000) In vivo transfer of hepatocyte growth factor gene accelerates proliferation of hepatic oval cells in a 2-acetylaminofluorene/partial hepatectomy model in rats. FEBS Lett 470: 325-330.
12. Azuma H, Takahara S, Matsumoto K, Ichimaru N, Wang JD, et al. (2001) Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. J Am Soc Nephrol 12: 1280-1292.
13. Yamaura K, Ito K, Tsukioka K, Wada Y, Makiuchi A, et al. (2004) Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy. Circulation 110: 1650-1657.
14. Chung H, Kim KH, Kim JG, Lee SY, Yoon YH, (2007) Retinal complications in patients with solid organ or bone marrow transplantations. Transplantation 83: 694-699.
15. Patel H, Vogl DT, Aqui N, Shaked A, Olthoff K, et al. (2007) Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases. Leuk Lymphoma 48: 885-891.
16. Tamsel S, Demirpolat G, Killi R, Aydin U, Kilic M, et al. (2007) Vascular complications after liver transplantation: evaluation with Doppler US. Abdom Imaging 32: 339-347.
17. Mukherjee S, Mukherjee U, (2009) A comprehensive review of immunosuppression used for liver transplantation. J Transplant 2009: 701464.
18. Aggarwal S, Pittenger MF, (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822.
19. Locke JE, Shamblott MJ, Cameron AM, (2009) Stem cells and the liver: clinical applications in transplantation. Adv Surg 43: 35-51.
20. Zimmermann FA, Knoll PP, Davies HS, Gokel JM, Schmid T, (1983) The fate of orthotopic liver allografts in different rat strain combinations. Transplant Proc 25: 1272.
21. Mosmann TR, Coffman RL, (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7: 145-173.
22. Chang JT, Reiner SL, (2008) Specifying helper T cell fates during immunity. J Pediatr Gastroenterol Nutr 46 Suppl 1: E19-20.
23. VanBuskirk AM, Wakely ME, Orosz CG, (1996) Transfusion of polarized TH2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection. Transplantation 62: 229-238.
24. Strom TB, Roy-Chaudhury P, Manfro R, Zheng XX, Nickerson PW, et al. (1996) The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 8: 688-693.
25. Marhaba R, Zoller M, (2004) CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 35: 211-231.
26. Hubbard AK, Rothlein R, (2000) Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med 28: 1379-1386.
27. Strasser A, Jost PJ, Nagata S, (2009) The many roles of FAS receptor signaling in the immune system. Immunity 30: 180-192.
28. Chatzigeorgiou A, Lyberi M, Chatzilymperis G, Nezos A, Kamper E, (2009) CD40/CD40L signaling and its implication in health and disease. Biofactors 35: 474-483.
29. Yang Y, Fukui K, Koike T, Zheng X, (2007) Induction of autophagy in neurite degeneration of mouse superior cervical ganglion neurons. Eur J Neurosci 26: 2979-2988.
30. Xie R, Xu SR, (2006) Two-cuff technique was applied in the establishment of orthotopic liver transplantation in rats. Journal of Jiangsu University (Medicine Edition) 16: 392-395.
31. Solez K, (2010) History of the Banff classification of allograft pathology as it approaches its 20th year. Curr Opin Organ Transplant 15: 49-51.